In the May/June issue of Medical Lab Management, Jane Hermansen, MBA, MT(ASCP), network manager for Mayo Medical Laboratories, discusses using quality assurance (QA) in the laboratory.
Recent Stories for Research
Novel BCR-ABL1 Fusion Identified by Targeted Next-Generation Sequencing in a Patient with an atypical Myeloproliferative Neoplasm
When standard molecular techniques fail in identifying rare and unusual tumor genetic variants, success is now being found through the use of next-generation sequencing (NGS).
A recent article in JAMA Neurology features a case report by a team of Mayo Clinic researchers that implies involvement of organs beyond the central nervous system in neuromyelitis optica spectrum disorders.
Other Posts for Research
- Clinical Utilization of Genomics Data
- Mayo Clinic Recommends New Routine Testing for Some Non-Hodgkin Lymphomas
- CAP TODAY: Urine Testing
- The Right and Wrong Way to Apply Bug Spray
- CAP TODAY: “Unraveling Metastasis With Circulating Tumor Cells”
- Clinical Chemistry: Quantification of Serum IgG Subclasses
- Clinical Chemistry: Assessing Direct-to-Consumer Genetic Testing (Update)
- Clinical Lab Products: “CDC Grant Supports Adoption of Evidence-Based Lab Guidelines”
- Genomic Testing for Breast Cancer Susceptibility Genes Helps Determine Enhanced Screening and Prevention Strategies
- Identifying the Costs of Transfusion Therapy